Background In the CLARITY AD study, lecanemab was shown to reduce markers of amyloid and slow cognitive decline at 18 months in early Alzheimer’s disease (AD). Here, we report the initial findings ...
Correspondence to: Dr Uta Schick Clinic of Neurological Surgery, Wedau Kliniken, Zu den Rehwiesen 9, 47055 Duisburg, Germany; Uta_Schickweb.de Objective: To present a large series of surgically ...
Department of Neurosurgery, University of Mississippi Medical Center, Jackson, Mississippi, USA Dr J Zhang, Department of Neurosurgery, University of Mississippi Medical Center, 2500 N State Street, ...
Computed tomography may be normal in up to 5% of patients who are investigated within one or two days after subarachnoid haemorrhage. This study investigated the need for further diagnostic evaluation ...
1 Department of Neurology, University of Iowa, Iowa City, Iowa, USA 2 Department of Neurology, University of Minnesota, Minneapolis, Minnesota, USA Correspondence to: Dr Praful Kelkar, Department of ...
Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas, USA Professor Joseph Jankovic, Parkinson's Disease Center and Movement ...
Correspondence to Dr Casey H Halpern, Department of Neurosurgery, Stanford University, Stanford, CA 94305-5327, USA; chalpern{at}stanford.edu Background The safety and efficacy of neuroablation (ABL) ...
Detailed neurological examinations, EEG and CT scans of the head were performed on 10 professional boxers aged 20 to 31 years shortly after being knocked-out. Intracerebral and subdural haematomas ...
Several features of amyotrophic lateral sclerosis (ALS) impact on sexuality and intimate relationship; however, the issue has received poor attention so far. We performed a systematic literature ...
Department of Medicine, University Hospital, Nottingham, UK. Data from 357 conscious stroke patients taking part in an acute intervention trial and assessed within 48 hours of the onset of symptoms, ...
Introduction Neurophysiology demonstrating conduction block (CB) and/or slowing (CS) in motor neuropathies usually prompts investigation for an acquired cause. We present three genetic causes for ...
Background Understanding the sequential progression of cognitive impairments in Parkinson’s disease (PD) is crucial for elucidating neuropathological underpinnings, refining the assessment of ...